Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine D-4 receptor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rowley, M; Bristow, LJ; Hutson, PH
      Current and novel approaches to the drug treatment of schizophrenia

      JOURNAL OF MEDICINAL CHEMISTRY
    2. Colabufo, NA; Berardi, F; Calo, R; Leopoldo, M; Perrone, R; Tortorella, V
      Determination of dopamine D-4 receptor density in rat striatum using PB12 as a probe

      EUROPEAN JOURNAL OF PHARMACOLOGY
    3. Franke, P; Nothen, MM; Wang, T; Knapp, M; Lichtermann, D; Neidt, H; Sander, T; Propping, P; Maier, W
      DRD4 exon IIIVNTR polymorphism-susceptibility factor for heroin dependence? Results of a case-control and a family-based association approach

      MOLECULAR PSYCHIATRY
    4. Langer, O; Halldin, C; Chou, YH; Sandell, J; Swahn, CG; Nagren, K; Perrone, R; Berardi, F; Leopoldo, M; Farde, L
      Carbon-11 PB-12: An attempt to visualize the dopamine D-4 receptor in the primate brain with positron emission tomography

      NUCLEAR MEDICINE AND BIOLOGY
    5. Staley, JK; Tamagnan, G; Baldwin, RM; Fujita, M; Al Tikriti, MS; Eshima, L; Thornback, J; Roe, D; Lu, L; Seibyl, JP; Innis, RB
      SPECT imaging with the D-4 receptor antagonist L-750,667 in nonhuman primate brain

      NUCLEAR MEDICINE AND BIOLOGY
    6. Clifford, JJ; Waddington, JL
      Topographically based search for an "ethogram" among a series of novel D-4dopamine receptor agonists and antagonists

      NEUROPSYCHOPHARMACOLOGY
    7. Gazi, L; Schoeffter, P; Nunn, C; Croskery, K; Hoyer, D; Feuerbach, D
      Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D-4 receptor

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    8. Oak, JN; Oldenhof, J; Van Tol, HHM
      The dopamine D-4 receptor: one decade of research

      EUROPEAN JOURNAL OF PHARMACOLOGY
    9. Tahar, AH; Belanger, N; Bangassoro, E; Gregoire, L; Bedard, PJ
      Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Obadiah, J; Avidor-Reiss, T; Fishburn, CS; Carmon, S; Bayewitch, M; Vogel, Z; Fuchs, S; Levavi-Sivan, B
      Adenylyl cyclase interaction with the D2 dopamine receptor family; Differential coupling to Gi, Gz, and Gs

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    11. Szoke, M; Sasvari-Szekely, M; Barta, C; Guttman, A
      Human dopamine D-4 receptor allele genotyping by ultrathin agarose gel electrophoresis with To-Pro-3 complexation

      ELECTROPHORESIS
    12. Chaki, S; Funakoshi, T; Yoshikawa, R; Okuyama, S; Kumagai, T; Nakazato, A; Nagamine, M; Tomisawa, K
      In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats

      NEUROPHARMACOLOGY
    13. Okuyama, S; Kawashima, N; Chaki, S; Yoshikawa, R; Funakoshi, T; Ogawa, S; Suzuki, Y; Ikeda, Y; Kumagai, T; Nakazato, A; Nagamine, M; Tomisawa, K
      A selective dopamine D-4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile

      LIFE SCIENCES
    14. Morishita, H; Katsuragi, T
      Existence and pharmacological properties of dopamine D-4 receptors in guinea pig vas deferens

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Gazi, L; Sommer, B; Nozulak, J; Schoeffter, P
      NGD 94-1 as an agonist at human recombinant dopamine D-4.4 receptors expressed in HEK293 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Helmeste, DM; Shioiri, T; Mitsuhashi, M; Tang, SW
      Binding of [H-3]U-101958 to sigma(1) receptor-like sites in human cerebellum and neuroblastoma cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Kula, NS; Tarazi, FI; Baldessarini, RJ; Xu, LX; Bakthavachalam, V; Pounds, S; True, CD
      Neuropharmacological assessment of potential dopamine D-4 receptor-selective radioligands

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Gazi, L; Bobirnac, I; Danzeisen, M; Schupbach, E; Langenegger, D; Sommer, B; Hoyer, D; Tricklebank, M; Schoeffter, P
      Receptor density as a factor governing the efficacy of the dopamine D-4 receptor ligands, L-745,870 and U-101958 at human recombinant D-4.4 receptorsexpressed in CHO cells

      BRITISH JOURNAL OF PHARMACOLOGY
    19. Watts, VJ; Vu, MN; Wiens, BL; Jovanovic, V; Van Tol, HHM; Neve, KA
      Short and long-term heterologous sensitization of adenylate cyclase by D-4dopamine receptors

      PSYCHOPHARMACOLOGY
    20. STEFANIS NC; BRESNICK JN; KERWIN RW; SCHOFIELD WN; MCALLISTER G
      ELEVATION OF D-4 DOPAMINE-RECEPTOR MESSENGER-RNA IN POSTMORTEM SCHIZOPHRENIC BRAIN

      Molecular brain research
    21. TARAZI FI; TOMASINI EC; BALDESSARINI RJ
      POSTNATAL-DEVELOPMENT OF DOPAMINE D-4-LIKE RECEPTORS IN RAT FOREBRAINREGIONS - COMPARISON WITH D-2-LIKE RECEPTORS

      Developmental brain research
    22. NOBLE EP; OZKARAGOZ TZ; RITCHIE TL; ZHANG XX; BELIN TR; SPARKES RS
      D-2 AND D-4 DOPAMINE-RECEPTOR POLYMORPHISMS AND PERSONALITY

      American journal of medical genetics
    23. WILSON JM; SANYAL S; VANTOL HHM
      DOPAMINE D-2 AND D-4 RECEPTOR LIGANDS - RELATION TO ANTIPSYCHOTIC ACTION

      European journal of pharmacology
    24. GAZI L; BOBIRNAC I; DANZEISEN M; SCHUPBACH E; BRUINVELS AT; GEISSE S; SOMMER B; HOYER D; TRICKLEBANK M; SCHOEFFTER P
      THE AGONIST ACTIVITIES OF THE PUTATIVE ANTIPSYCHOTIC AGENTS, L-745,870 AND U-101958 IN HEK293 CELLS EXPRESSING THE HUMAN DOPAMINE D-4.4 RECEPTOR

      British Journal of Pharmacology
    25. MANSBACH RS; BROOKS EW; SANNER MA; ZORN SH
      SELECTIVE DOPAMINE D-4 RECEPTOR ANTAGONISTS REVERSE APOMORPHINE-INDUCED BLOCKADE OF PREPULSE INHIBITION

      Psychopharmacology
    26. CHAVEZENG CM; CONSTANZER ML; MATUSZEWSKI BK
      PICOGRAM DETERMINATION OF A NOVEL DOPAMINE D-4 RECEPTOR ANTAGONIST INHUMAN PLASMA AND URINE BY LIQUID-CHROMATOGRAPHY WITH ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION TANDEM MASS-SPECTROMETRY

      Journal of chromatography B. Biomedical sciences and applications
    27. TARAZI FI; KULA NS; BALDESSARINI RJ
      REGIONAL DISTRIBUTION OF DOPAMINE D-4 RECEPTORS IN RAT FOREBRAIN

      NeuroReport
    28. KUROKAWA K; NARITA M; KOSHIYA K; HIDAKA K; OHMORI J; SATOH K
      EFFECTS OF YM-43611, A NOVEL DOPAMINE D-2-LIKE RECEPTOR ANTAGONIST, ON IMMEDIATE-EARLY GENE-EXPRESSION IN THE RAT FOREBRAIN

      Neuropsychopharmacology
    29. ZAWILSKA JB; DERBISZEWSKA T; NOWAK JZ
      PROLONGED EXPOSURE OF CHICKS TO LIGHT OR DARKNESS DIFFERENTIALLY AFFECTS THE QUINPIROLE-EVOKED SUPPRESSION OF SEROTONIN N-ACETYLTRANSFERASEACTIVITY IN CHICK RETINA - AN IMPACT ON DOPAMINE D-4-LIKE RECEPTOR

      Journal of pineal research
    30. MULCRONE J; KERWIN RW
      THE REGIONAL PATTERN OF D4 GENE-EXPRESSION IN HUMAN BRAIN

      Neuroscience letters
    31. RICCI A; BRONZETTI E; FELICI L; TAYEBATI SK; AMENTA F
      DOPAMINE D-4 RECEPTOR IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTES - A RADIOLIGAND BINDING ASSAY STUDY

      Neuroscience letters
    32. SHIH YH; CHUNG FZ; PUGSLEY TA
      CLONING, EXPRESSION AND CHARACTERIZATION OF A HUMAN DOPAMINE D-4.2 RECEPTOR (CHO K1 CELLS) AND VARIOUS D-4.2 D-2L CHIMERAS (COS-7 CELLS)/

      Progress in neuro-psychopharmacology & biological psychiatry
    33. VESSOTSKIE JM; KUNG MP; CHUMPRADIT S; KUNG HF
      CHARACTERIZATION OF [I-125] S(-)5-OH-PIPAT BINDING TO DOPAMINE D-2-LIKE RECEPTORS EXPRESSED IN CELL-LINES

      Neuropharmacology
    34. JENSEN BS; LEVAVISIVAN B; FISHBURN CS; FUCHS S
      FUNCTIONAL EXPRESSION OF THE MURINE D-2, D-3 AND D-4 DOPAMINE-RECEPTORS IN XENOPUS-LAEVIS OOCYTES

      FEBS letters
    35. CAO BJ; RODGERS RJ
      DOPAMINE D-4 RECEPTOR AND ANXIETY - BEHAVIORAL PROFILES OF CLOZAPINE,L-745,870 AND L-741,742 IN THE MOUSE PLUS-MAZE

      European journal of pharmacology
    36. KULA NS; BALDESSARINI RJ; KEBABIAN JW; BAKTHAVACHALAM V; XU LX
      RBI-257 - A HIGHLY POTENT DOPAMINE D-4 RECEPTOR-SELECTIVE LIGAND

      European journal of pharmacology
    37. SCHLACHTER SK; POEL TJ; LAWSON CF; DINH DM; LAJINESS ME; ROMERO AG; REES SA; DUNCAN JN; SMITH MW
      SUBSTITUTED 4-AMINOPIPERIDINES HAVING HIGH IN-VITRO AFFINITY AND SELECTIVITY FOR THE CLONED HUMAN DOPAMINE D-4 RECEPTOR

      European journal of pharmacology
    38. NEWMANTANCREDI A; AUDINOTBOUCHEZ V; GOBERT A; MILLAN MJ
      NORADRENALINE AND ADRENALINE ARE HIGH-AFFINITY AGONISTS AT DOPAMINE D-4 RECEPTORS

      European journal of pharmacology
    39. OKUYAMA S; CHAKI S; KAWASHIMA N; SUZUKI Y; OGAWA S; KUMAGAI T; NAKAZATO A; NAGAMINE M; YAMAGUCHI K; TOMISAWA K
      THE ATYPICAL ANTIPSYCHOTIC PROFILE OF NRA0045, A NOVEL DOPAMINE D-4 AND 5-HYDROXYTRYPTAMINE(2A) RECEPTOR ANTAGONIST, IN RATS

      British Journal of Pharmacology
    40. TANG SW; HELMESTE DM; FANG H; LI M; VU R; BUNNEY W; POTKIN S; JONES EG
      DIFFERENTIAL LABELING OF DOPAMINE AND SIGMA-SITES BY [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IN POSTMORTEM HUMAN BRAINS

      Brain research
    41. MALHOTRA AK; VIRKKUNEN M; ROONEY W; EGGERT M; LINNOILA M; GOLDMAN D
      THE ASSOCIATION BETWEEN THE DOPAMINE D-4 RECEPTOR (D4DR) 16 AMINO-ACID REPEAT POLYMORPHISM AND NOVELTY SEEKING

      Molecular psychiatry
    42. RIETSCHEL M; NABER D; OBERLANDER H; HOLZBACH R; FIMMERS R; EGGERMANN K; MOLLER HJ; PROPPING P; NOTHEN MM
      EFFICACY AND SIDE-EFFECTS OF CLOZAPINE - TESTING FOR ASSOCIATION WITHALLELIC VARIATION IN THE DOPAMINE D-4 RECEPTOR GENE

      Neuropsychopharmacology
    43. ZAWILSKA JB; DERBISZEWSKA T; NOWAK JZ
      PHARMACOLOGICAL MODIFICATIONS IN DOPAMINERGIC NEUROTRANSMISSION AFFECT THE QUINPIROLE-EVOKED SUPPRESSION OF SEROTONIN N-ACETYLTRANSFERASE ACTIVITY IN CHICK RETINA - AN IMPACT ON DOPAMINE D-4-LIKE RECEPTORS

      Journal of neural transmission
    44. CHEONG JS; KIM AY; KIM KM
      IDENTIFICATION OF CERTAIN SEQUENCES IN THE 3RD CYTOPLASMIC LOOP OF D-4 DOPAMINE-RECEPTOR THAT SUPPRESS THE BACTERIAL EXPRESSION

      Archives of pharmacal research
    45. BARR CL; WIGG KG; ZOVKO E; SANDOR P; TSUI LC
      NO EVIDENCE FOR A MAJOR GENE EFFECT OF THE DOPAMINE D-4 RECEPTOR GENEIN THE SUSCEPTIBILITY TO GILLES-DE-LA-TOURETTE SYNDROME IN 5 CANADIANFAMILIES

      American journal of medical genetics
    46. ZAWILSKA JB
      MELATONIN AS A CHEMICAL INDICATOR OF ENVIRONMENTAL LIGHT-DARK CYCLE

      Acta Neurobiologiae Experimentalis
    47. HELMESTE DM; TANG SW; BUNNEY WE; POTKIN SG; JONES EG
      DECREASE IN SIGMA BUT NO INCREASE IN STRIATAL DOPAMINE D-4 SITES IN SCHIZOPHRENIC BRAINS

      European journal of pharmacology
    48. HEUILLET E; PETITET F; MIGNANI S; MALLERON JL; LAVAYRE J; NELIAT G; DOBLE A; BLANCHARD JC
      THE NAPHTOSULTAM DERIVATIVE RP-62203 (FANANSERIN) HAS HIGH-AFFINITY FOR THE DOPAMINE D-4 RECEPTOR

      European journal of pharmacology
    49. HELMESTE D; TANG SW; FANG H; LI M
      BRAIN SIGMA-RECEPTORS LABELED BY [H-3] NEMONAPRIDE

      European journal of pharmacology
    50. HIDAKA K; TADA S; MATSUMOTO M; OHMORI J; TASAKI Y; NOMURA T; USUDA S; YAMAGUCHI T
      IN-VITRO PHARMACOLOGICAL PROFILE OF YM-43611, A NOVEL D-2-LIKE RECEPTOR ANTAGONIST WITH HIGH-AFFINITY AND SELECTIVITY FOR DOPAMINE D-3 AND D-4 RECEPTORS

      British Journal of Pharmacology
    51. SEEMAN P; VANTOL HHM
      DERIVING THE THERAPEUTIC CONCENTRATIONS FOR CLOZAPINE AND HALOPERIDOL- THE APPARENT DISSOCIATION-CONSTANT OF A NEUROLEPTIC AT THE DOPAMINED-2 OR D-4 RECEPTOR VARIES WITH THE AFFINITY OF THE COMPETING RADIOLIGAND

      European journal of pharmacology. Molecular pharmacology section
    52. BOUVIER C; BUNZOW JR; GUAN HC; UNTEUTSCH A; CIVELLI O; GRANDY DK; VANTOL HHM
      FUNCTIONAL-CHARACTERIZATION OF THE HUMAN DOPAMINE D-4.2 RECEPTOR USING VACCINIA VIRUS AS AN EXPRESSION SYSTEM

      European journal of pharmacology. Molecular pharmacology section
    53. SCHOOTS O; SEEMAN P; GUAN HC; PATERSON AD; VANTOL HHM
      LONG-TERM HALOPERIDOL ELEVATES DOPAMINE D-4 RECEPTORS BY 2-FOLD IN RATS

      European journal of pharmacology. Molecular pharmacology section
    54. SUZUKI T; KOBAYASHI K; NAGATSU T
      GENOMIC STRUCTURE AND TISSUE DISTRIBUTION OF THE MOUSE DOPAMINE D-4 RECEPTOR

      Neuroscience letters
    55. KUSUMI I; MATSUBARA S; TAKAHASHI Y; ISHIKANE T; KOYAMA T
      CHARACTERIZATION OF [H-3] CLOZAPINE BINDING-SITES IN RAT-BRAIN

      Journal of neural transmission
    56. KUSUMI I; ISHIKANE T; MATSUBARA S; KOYAMA T
      LONG-TERM TREATMENT WITH HALOPERIDOL OR CLOZAPINE DOES NOT AFFECT DOPAMINE D-4 RECEPTORS IN RAT FRONTAL-CORTEX

      Journal of neural transmission
    57. NAIR VD; MISHRA RK
      ONTOGENIC DEVELOPMENT OF DOPAMINE D-4 RECEPTOR IN RAT-BRAIN

      Developmental brain research
    58. DURCAN MJ; RIGDON GC; NORMAN MH; MORGAN PF
      IS CLOZAPINE SELECTIVE FOR THE DOPAMINE D-4 RECEPTOR

      Life sciences
    59. GLAVIN GB
      THE ANTISECRETORY EFFECTS OF CLOZAPINE, A DOPAMINE D-4 RECEPTOR ANTAGONIST, ARE BLOCKED BY THE DOPAMINE D-1 RECEPTOR ANTAGONIST, SCH23390

      Life sciences
    60. REYNOLDS GP; MASON SL
      ABSENCE OF DETECTABLE STRIATAL DOPAMINE D-4 RECEPTORS IN DRUG-TREATEDSCHIZOPHRENIA

      European journal of pharmacology
    61. LIEGEOIS JF; BRUHWYLER J; DAMAS J; ROGISTER F; MASEREEL B; GECZY J; DELARGE J
      MODULATION OF THE CLOZAPINE STRUCTURE INCREASES ITS SELECTIVITY FOR THE DOPAMINE D-4 RECEPTOR

      European journal of pharmacology
    62. SUMIYOSHI T; STOCKMEIER CA; OVERHOLSER JC; THOMPSON PA; MELTZER HY
      DOPAMINE D-4 RECEPTORS AND EFFECTS OF GUANINE-NUCLEOTIDES ON [H-3] RACLOPRIDE BINDING IN POSTMORTEM CAUDATE-NUCLEUS OF SUBJECTS WITH SCHIZOPHRENIA OR MAJOR DEPRESSION

      Brain research
    63. ROTH BL; TANDRA S; BURGESS LH; SIBLEY DR; MELTZER HY
      D-4 DOPAMINE-RECEPTOR BINDING-AFFINITY DOES NOT DISTINGUISH BETWEEN TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS

      Psychopharmacology
    64. ZAWILSKA JB
      STIMULATION OF D-4-LIKE DOPAMINE-RECEPTOR SUPPRESSES SEROTONIN N-ACETYLTRANSFERASE ACTIVITY BUT DOES NOT PHASE-SHIFT THE CIRCADIAN OSCILLATOR IN CHICK RETINA

      Neuroscience letters
    65. FLAMEZ A; DEBACKER JP; WILCZAK N; VAUQUELIN G; DEKEYSER J
      [3H]CLOZAPINE IS NOT A SUITABLE RADIOLIGAND FOR THE LABELING OF D-4 DOPAMINE-RECEPTORS IN POSTMORTEM HUMAN BRAIN

      Neuroscience letters
    66. MCHALE M; COLDWELL MC; HERRITY N; BOYFIELD I; WINN FM; BALL S; COOK T; ROBINSON JH; GLOGER IS
      EXPRESSION AND FUNCTIONAL-CHARACTERIZATION OF A SYNTHETIC VERSION OF THE HUMAN D-4 DOPAMINE-RECEPTOR IN A STABLE HUMAN CELL-LINE

      FEBS letters
    67. BARR CL; KENNEDY JL; LICHTER JB; VANTOL HHM; WETTERBERG L; LIVAK KJ; KIDD KK
      ALLELES AT THE DOPAMINE D-4 RECEPTOR LOCUS DO NOT CONTRIBUTE TO THE GENETIC SUSCEPTIBILITY TO SCHIZOPHRENIA IN A LARGE SWEDISH KINDRED

      American journal of medical genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 15:10:57